This FSRH Guidance provides key information and good practice points for health professionals on drug-drug interactions (DDIs) between HIV antiretroviral therapy (ART) and contraception to facilitate the prescription of safe and effective contraception to people living with HIV and on ART.
Guide to becoming an Essentials Facilitator
This guideline provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only contraceptive pills. It is intended for any healthcare professional or health service providing contraceptive care in the UK. In this version of the POP Guideline, the supporting evidence for the recommendations has been removed from the main text and located in an appendix for ease of reading. This document is available to FSRH members and candidates only.
This guideline provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only contraceptive pills. It is intended for any health care professional or health service providing contraceptive care in the UK.
Also available in digital format on the BMJ website: FSRH Guideline (August 2022) Progestogen-only Pills. BMJ Sexual & Reproductive Health 2022; 48:Suppl 1.
This summary has been written as a quick reference guide to help busy clinicians to give clear, safe advice on progestogen-only contraceptive pills. Please refer to the full 2022 FSRH Progestogen-only Pills Clinical Guideline for further information and supporting evidence for this advice. This document is written for FSRH members and requires you to log in to access it.
Half-Day Hot Topic Event: Complex SRH and Gynaecological Issues certificate of attendance. You can download and print this certificate.
RCOG - RCM - FSRH - BSACP Telemedicine Safeguarding Statement May 2022
This FSRH Guidance provides evidence-based recommendations and good practice points for health professionals on drug Interaction with Hormonal Contraception. It is intended for use by health professionals working in sexual and reproductive health, general practice, and obstetric and gynaecology settings.
21.02.22 MHRA Gina vaginal HRT reclassification consultation response from FSRH, RCOG and BMS
Download the LoC SDI-IO form. January 2023
